# Lineage Cell Therapeutics, Inc.: Form 8-K, filed Feb 15, 2024

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: 8-K
- Filed: 2024-02-15
- Accepted by EDGAR: Feb 15, 2024, 17:27 ET
- Period: 2024-02-14
- Accession: 0001493152-24-006901
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000149315224006901/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000149315224006901/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000149315224006901/form8-k.htm

Filed Feb 15, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-006901. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.